Long-term efficacy and safety of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 7 years in a real world setting: The experience of a reference Hospital in the Canary Islands

doi:10.1016/j.jaad.2019.06.1048

Long-term efficacy and safety of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 7 years in a real world setting: The experience of a reference Hospital in the Canary Islands

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.1048 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB233

Keyword(s):

Canary Islands ◽

Real World ◽

Severe Psoriasis ◽

Efficacy And Safety ◽

Term Efficacy ◽

Real World Setting ◽

Reference Hospital

Download Full-text

Successful treatment of severe psoriasis relapse with secukinumab (interleukin 17 A inhibitor) after abrupt brodalumab (interleukin 17 receptor inhibitor) discontinuation: A retrospective study evaluating long-term efficacy and safety

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.03.027 ◽

2018 ◽

Vol 79 (4) ◽

pp. 758-760 ◽

Cited By ~ 2

Author(s):

Abdallah Khemis ◽

Awatef Kelati ◽

Henri Montaudié ◽

Jean-Philippe Lacour ◽

Thierry Passeron

Keyword(s):

Retrospective Study ◽

Successful Treatment ◽

Severe Psoriasis ◽

Interleukin 17 ◽

Efficacy And Safety ◽

Term Efficacy ◽

Receptor Inhibitor

Download Full-text

26874 Long-term efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who were partial responders or nonresponders to etanercept: Post hoc analysis through 5 years from the reSURFACE 2 phase 3 trial

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.496 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB119

Author(s):

Diamant Thaçi ◽

Christopher E.M. Griffiths ◽

Lars Iversen ◽

Andrea Peserico ◽

Ignasi Pau-Charles ◽

...

Keyword(s):

Severe Psoriasis ◽

Efficacy And Safety ◽

Phase 3 ◽

Post Hoc Analysis ◽

Term Efficacy ◽

Post Hoc

Download Full-text

Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks

British Journal of Dermatology ◽

10.1111/bjd.18232 ◽

2019 ◽

Vol 182 (3) ◽

pp. 605-617 ◽

Cited By ~ 18

Author(s):

K. Reich ◽

R.B. Warren ◽

L. Iversen ◽

L. Puig ◽

I. Pau‐Charles ◽

...

Keyword(s):

Clinical Trials ◽

Severe Psoriasis ◽

Phase Iii ◽

Efficacy And Safety ◽

Term Efficacy ◽

Phase Iii Clinical Trials

Download Full-text

499 Long-term efficacy of secukinumab in Korean patients with moderate-to-severe plaque psoriasis in a real-world setting; A single-center, retrospective study

Journal of Investigative Dermatology ◽

10.1016/j.jid.2020.03.508 ◽

2020 ◽

Vol 140 (7) ◽

pp. S68

Author(s):

J. Park ◽

S. Lee

Keyword(s):

Retrospective Study ◽

Real World ◽

Plaque Psoriasis ◽

Single Center ◽

Severe Plaque Psoriasis ◽

Korean Patients ◽

Term Efficacy ◽

Real World Setting

Download Full-text

Long‐term efficacy and safety of ustekinumab for moderate‐to‐severe psoriasis: a 9‐year real‐life experience from a tertiary referral center in Turkey

Dermatologic Therapy ◽

10.1111/dth.15042 ◽

2021 ◽

Author(s):

Goncagül Babuna Kobaner ◽

Algün Polat Ekinci ◽

Armağan Kutlay

Keyword(s):

Life Experience ◽

Real Life ◽

Severe Psoriasis ◽

Efficacy And Safety ◽

Tertiary Referral ◽

Tertiary Referral Center ◽

Referral Center ◽

Term Efficacy

Download Full-text

Long‐term efficacy and safety of infliximab maintenance therapy in patients with plaque‐type psoriasis in real‐world practice

British Journal of Dermatology ◽

10.1111/bjd.13004 ◽

2014 ◽

Vol 171 (3) ◽

pp. 631-641 ◽

Cited By ~ 24

Author(s):

N.H. Shear ◽

M. Hartmann ◽

M. Toledo‐Bahena ◽

A. Katsambas ◽

L. Connors ◽

...

Keyword(s):

Maintenance Therapy ◽

Real World ◽

Efficacy And Safety ◽

Term Efficacy ◽

Plaque Type

Download Full-text

Use of apremilast for the treatment of plaque psoriasis in a real world setting. The experience of a reference hospital in the Canary Islands

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.536 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB143

Keyword(s):

Canary Islands ◽

Real World ◽

Plaque Psoriasis ◽

Real World Setting ◽

Reference Hospital

Download Full-text

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.183825 ◽

2016 ◽

Vol 20 (5) ◽

pp. 595 ◽

Cited By ~ 2

Author(s):

Parjeet Kaur ◽

Shama Mahendru ◽

Ambrish Mithal

Keyword(s):

Type 2 Diabetes ◽

Real World ◽

Term Efficacy ◽

Real World Setting ◽

Indian Patients

Download Full-text

Use of secukinumab for the treatment of plaque psoriasis in a real world setting: The experience of a reference hospital in the Canary Islands

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2017.04.1075 ◽

2017 ◽

Vol 76 (6) ◽

pp. AB277

Keyword(s):

Canary Islands ◽

Real World ◽

Plaque Psoriasis ◽

Real World Setting ◽

Reference Hospital

Download Full-text

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2010.12.005 ◽

2012 ◽

Vol 66 (2) ◽

pp. 241-251 ◽

Cited By ~ 99

Author(s):

Kenneth Gordon ◽

Kim Papp ◽

Yves Poulin ◽

Yihua Gu ◽

Stephen Rozzo ◽

...

Keyword(s):

Severe Psoriasis ◽

Extension Study ◽

Efficacy And Safety ◽

Open Label ◽

Term Efficacy ◽

Open Label Extension

Download Full-text